KIRBY KNUTH: Open Payments
NPI 1649750126 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 19 payments from 10 companies in 2025. Trend: 2023 $402 · 2024 $539 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Organogenesis Inc. | 1 | $42 |
| ABIOMED | 2 | $38 |
| PFIZER INC. | 2 | $34 |
| Amgen Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| PolyNovo North America LLC | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $4 |
Products named: CAMZYOS, PURAPLY WOUND MATRIX, FARXIGA, VYNDAQEL, REPATHA, JARDIANCE, NOVOSORB BTM, LEQVIO.
Industry payments across NE — which companies pay providers there.
